Page 43 - Krishna Kant

India Inc generous with dividends in tough times

Investments yield little returns for Tata Sons

Excluding TCS, dividend income down to a trickle; Tata Sons, however, says market cap of listed entities grew much more than that of Sensex over 10 years

In Q4, revenue cheer and profit woes

Rise in revenue after five quarters as commodity prices bottom out and software exporters grow faster

Earnings of Sensex companies: March to be best in 7 qtrs

Combined net profit estimated to grow 14.6% year-on-year, against a 5.7% decline in the Dec 2015 quarter

Infy founders have little to complain about Sikka's performance

The company's stock is nearly 50 per cent higher than in June 2014, when Sikka took over, and the momentum favours it over peers

Indian firms lead AAA league table

73 such listed entities here, against 14 in China, six in Japan and two in America; analysts caution, for reasons, against reading too much into this

Corporate tax: Jaitley's big push for small businesses

Rs 4,300-crore dividend tax blow for promoters

Will stocks deliver in 2016?

Sensex gets expensive for 4th straight year

Longest period of expansion in price-earning ratio since 1996

A fifth of corporate debt in troubled waters

67 companies with total debt of Rs 5.65 lakh cr were either loss-making or didn't generate enough profit to cover interest cost in FY15

Many air pockets in India Inc's global flight

Big-ticket buyouts at the peak of valuation cycle failed to live up to the hype; smaller deals did better

US Fed rate hike: Cloud over India's premium valuations

Premium valuations era started in 2006 and went hand in hand with decline in the US interest rates

Cash flow of high-debt firms turns positive after 10 years

This is largely because of a sharp cut in capex and investments rather than any material improvement in cash flow generation from operations

Havells may have to take haircut on its investment in Sylvania

The company may not recover the funds invested to acquire and sustain Sylvania since 2007

Monetary policy is losing its sting

In FY15, every incremental rupee of money supply generated just Rs 1.2 of incremental gross domestic product

Focus on pharma IPOs next week

Sources say Alkem Laboratories' Rs 1,350-crore IPO and Dr Lal PathLabs' Rs 633-crore IPO will open from December 7 to 9

Sensex makes a defensive play

Share of IT, pharma, and FMCG companies in Sensex to rise to 38% next month; manufacturing losing sheen

D-Street more financialised than Wall Street

Banks and finance firms accounted for 31% of BSE 500 companies' profits in 2014-15 versus their 20.6% profit share in S&P 500

Low demand eats into input cost benefits

Core operating margins in July-Sept quarter down 165 basis points, sequentially

India Inc's sales, profit move in opposite directions

Net sales growth decline 4.4% in September quarter, the second worst in eight years; net profit grows at the fastest pace in four quarters